VALEANT INTERNAT BERMUDA has a total of 12 patent applications. Its first patent ever was published in 2004. It filed its patents most often in United States, Norway and Australia. Its main competitors in its focus markets pharmaceuticals and organic fine chemistry are SULTANOV VAGIF SULTANOVICH, LABORATORIOS MENARINI S A and HEALTHPARTNERS RES FOUNDATION.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 5 | |
#2 | Norway | 4 | |
#3 | Australia | 1 | |
#4 | Japan | 1 | |
#5 | Malaysia | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Organic fine chemistry |
# | Technology | |
---|---|---|
#1 | Medical preparations | |
#2 | Therapeutic chemical compounds | |
#3 | Organic chemistry methods | |
#4 | Acyclic or carbocyclic compounds |
# | Name | Total Patents |
---|---|---|
#1 | Maes Paul | 4 |
#2 | Zhou Fang | 4 |
#3 | Turchetta Stefano | 3 |
#4 | Oberegger Werner | 3 |
#5 | Jackson Graham | 3 |
#6 | Eradiri Okpo | 2 |
#7 | Seth Pawan | 2 |
#8 | Saleh Mohammad Ashty | 2 |
#9 | Zenoni Maurizio | 2 |
#10 | Silverstone Peter Harris | 1 |
Publication | Filing date | Title |
---|---|---|
JP2014177488A | Bupropion hydrochloride modified-release tablet | |
US2014030249A1 | Pharmaceutical Compositions | |
AU2013213664A1 | Bupropion hydrobromide and therapeutic applications | |
MY150646A | Modified release formulations of a bupropion salt |